Does DAPAGLIFLOZIN Cause Coronary artery occlusion? 29 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 29 reports of Coronary artery occlusion have been filed in association with DAPAGLIFLOZIN (QTERN). This represents 0.1% of all adverse event reports for DAPAGLIFLOZIN.
29
Reports of Coronary artery occlusion with DAPAGLIFLOZIN
0.1%
of all DAPAGLIFLOZIN reports
0
Deaths
24
Hospitalizations
How Dangerous Is Coronary artery occlusion From DAPAGLIFLOZIN?
Of the 29 reports, 24 (82.8%) required hospitalization, and 1 (3.4%) were considered life-threatening.
Is Coronary artery occlusion Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for DAPAGLIFLOZIN. However, 29 reports have been filed with the FAERS database.
What Other Side Effects Does DAPAGLIFLOZIN Cause?
Death (2,775)
Diabetic ketoacidosis (1,773)
Acute kidney injury (982)
Off label use (891)
Nausea (884)
Dehydration (860)
Vomiting (838)
Dizziness (817)
Ketoacidosis (803)
Fatigue (785)
What Other Drugs Cause Coronary artery occlusion?
ADALIMUMAB (1,392)
TICAGRELOR (370)
CALCIUM\DEXTROSE\MAGNESIUM\SODIUM\SODIUM (296)
ROSUVASTATIN (283)
METOPROLOL (230)
SACUBITRIL\VALSARTAN (204)
ASPIRIN (190)
RISANKIZUMAB-RZAA (181)
EVOLOCUMAB (162)
CLOPIDOGREL BISULFATE (155)
Which DAPAGLIFLOZIN Alternatives Have Lower Coronary artery occlusion Risk?
DAPAGLIFLOZIN vs DAPAGLIFLOZIN PROPANEDIOL
DAPAGLIFLOZIN vs DAPAGLIFLOZIN PROPANEDIOL\METFORMIN
DAPAGLIFLOZIN vs DAPRODUSTAT
DAPAGLIFLOZIN vs DAPSONE
DAPAGLIFLOZIN vs DAPTOMYCIN